1. Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials. (13th April 2016) Authors: Taboada, Maria; Melnick, David; Iaconis, Joseph P.; Sun, Fang; Zhong, Nan Shan; File, Thomas M.; Llorens, Lily; Friedland, H. David; Wilson, David Journal: Journal of antimicrobial chemotherapy Issue: Volume 71:Number 6(2016:Jun.) Page Start: 1748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial. Issue 9 (September 2017) Authors: Maio, Michele; Scherpereel, Arnaud; Calabrò, Luana; Aerts, Joachim; Perez, Susana Cedres; Bearz, Alessandra; Nackaerts, Kristiaan; Fennell, Dean A; Kowalski, Dariusz; Tsao, Anne S; Taylor, Paul; Grosso, Federica; Antonia, Scott J; Nowak, Anna K; Taboada, Maria; Puglisi, Martina; Stockman, Paul K;... Journal: Lancet oncology Issue: Volume 18:Issue 9(2017:Sep.) Page Start: 1261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exposure–Response Analysis of Overall Survival for Tremelimumab in Unresectable Malignant Mesothelioma: The Confounding Effect of Disease Status. Issue 5 (12th April 2019) Authors: Baverel, Paul; Roskos, Lorin; Tatipalli, Manasa; Lee, Nancy; Stockman, Paul; Taboada, Maria; Vicini, Paolo; Horgan, Kevin; Narwal, Rajesh Journal: Clinical and translational science Issue: Volume 12:Issue 5(2019) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗